InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

Current share price for ATH : $0.670 0.02 (3.08%)+

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$146 Alterity Announces Late-Breaker Oral Presentation at AAN 16 Apr 2026 12:35PM $0.008 $0.670 risen by 8,275%
$146 Alterity to Host KOL Event to Share New Insights on ATH434 15 Apr 2026 10:55AM $0.009 $0.670 risen by 7,344.44%
$146 Corporate Presentation April 2026 1 Apr 2026 2:01PM $0.009 $0.670 risen by 7,344.44%
$146 Alterity Receives Positive FDA Feedback From Type C Meeting 30 Mar 2026 9:57AM $0.008 $0.670 risen by 8,275%
$146 Notification regarding unquoted securities - ATH 26 Mar 2026 6:16PM $0.007 $0.670 risen by 9,471.43%
$146 Proposed issue of securities - ATH 19 Mar 2026 5:00PM $0.008 $0.670 risen by 8,275%
$146 Unmarketable Parcel Sale Facility 12 Mar 2026 1:32PM $0.008 $0.670 risen by 8,275%
$146 Alterity to Participate in the Bell Potter Healthcare Summit 9 Mar 2026 11:40AM $0.008 $0.670 risen by 8,275%
$146 Dr Daniel Claassen as Chief Medical Advisor 4 Mar 2026 9:31AM $0.007 $0.670 risen by 9,471.43%
$146 Half Yearly Report and Accounts 26 Feb 2026 9:19AM $0.008 $0.670 risen by 8,275%
$146 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 10:04AM $0.008 $0.670 risen by 8,275%
$146 ATH Shareholder Letter January 2026 21 Jan 2026 10:14AM $0.008 $0.670 risen by 8,275%
$146 Notification regarding unquoted securities - ATH 15 Jan 2026 12:52PM $0.008 $0.670 risen by 8,275%
$146 Notification regarding unquoted securities - ATH 15 Jan 2026 12:23PM $0.008 $0.670 risen by 8,275%
$146 Corporate Presentation 13 Jan 2026 10:49AM $0.008 $0.670 risen by 8,275%
$146 Change of Director's Interest Notice - D Stamler 7 Jan 2026 11:31AM $0.009 $0.670 risen by 7,344.44%
$146 Notification of cessation of securities - ATH 7 Jan 2026 11:08AM $0.009 $0.670 risen by 7,344.44%
$146 Initial Director's Interest Notice - Barbaczy 24 Nov 2025 3:48PM $0.009 $0.670 risen by 7,344.44%
$146 Initial Director's Interest Notice - Stamler 24 Nov 2025 3:47PM $0.009 $0.670 risen by 7,344.44%
$146 Final Director's Interest Notice - Meltzer 24 Nov 2025 1:07PM $0.010 $0.670 risen by 6,600%
$146 Final Director's Interest Notice - Kempler 24 Nov 2025 1:06PM $0.010 $0.670 risen by 6,600%
$146 Results of Meeting 21 Nov 2025 12:48PM $0.009 $0.670 risen by 7,344.44%
$146 Presentation to Annual General Meeting 21 Nov 2025 10:45AM $0.009 $0.670 risen by 7,344.44%
$146 Chairman's Address 2025 Annual General Meeting 21 Nov 2025 10:35AM $0.009 $0.670 risen by 7,344.44%
$146 Alterity Board Changes 21 Nov 2025 9:20AM $0.009 $0.670 risen by 7,344.44%

26 - 50 of 544 results

Page 2 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.